They were 10mg tablets, here's the old FDA complant about them -
COMPLAINT FILED : September 29, 1949, Southern District of California, against
the Hudson Products Co., a corporation, Long Beach, Calif., also trading under
the name of the Maywood Pharmacal Co., at Hollywood, Calif., and against
Allen H. Parkinson, president of the Hudson Products Co.
ALLEGED VIOLATION: The complaint alleged that the defendants were distrib-
utors of certain male and female hormones; that the male hormones consisted
of methyltestosterone tablets (10 milligrams), methyltestosterone linguets
*See also No. 3550.
and that the female hormones consisted of tablets containing 0.1 milligram
alpha-estradiol.
The complaint alleged also that the defendants were violating Section 301
(a) of the Act by causing the introduction into interstate commerce of the 5
milligram methyltestosterone linguets and the methyltestosterone linguets
combined with vitamin Bi, which were misbranded as follows:
Section 502 (a), the labeling of the linguets was false and misleading since
the labeling represented and suggested that the recommended daily dosage
was efficacious for use in the treatment of the male hormone deficiency,
whereas the recommended daily dosage would be entirely ineffective for such
purpose; Section 502 (f) (1), the labeling of the linguets failed to bear ade-
quate directions for use since it failed to state all of the diseases or conditions
of the body for which the drug was intended; and Section 502 (f) (2), the
labeling of the linguets failed to bear adequate warnings against use in those
pathological conditions where their use may be dangerous to health, in such
manner and form, as are necessary for the protection of the user since the tech-
nical medical terminology in which the cautionary statement on the labeling
was couched was inadequate to warn the ordinary lay user that their use may
accelerate the malignant growth of the prostrate gland or may cause sterility.
- It was alleged also with respect to the methyltestosterone tablets and the
alpha-estradiol preparations that the defendants would likely cause the same
violations of Section 301 (a) of the Act as they were causing with respect
to the linguets since the defendants had sold in the past such products without
a physician's prescription and without adequate warnings and since the un-
restricted use of alpha-estradiol preparations by women may accelerate the
malignant growth of cancer of the breast, cervix, and uterus, and may cause
injury to the female generative system.
DISPOSITION : On January 11, 1950, after a hearing on the issuance of a pre-
liminary injunction, the application for such injunction was denied. The case
then was consolidated with that against the Bl-O-Pathic Pharmacy, et al,
reported in notices of judgment on drugs and devices, No. 3550. After the
consolidated cases came on for trial before the court on January 31, 1950,
judgment was rendered in such cases, denying the Government's application
for permanent injunction. Upon appeal, the judgment was reversed and the
cases were remanded to the district court for the entry of a decree of per-
manent injunction in each case.
On July 31, 1951, findings of fact and conclusions of law were filed, sup-
porting the issuance of a permanent injunction, and on the same day an
order was entered permanently enjoining the Hudson Products Co., the May-
wood Pharmacal Co., and Allen H. Parkinson from violating Section 301 (a)
by distributing male or female sex hormone drugs misbranded under Sections
502 (a), 502 (f) (1), or 502 (f) (2).
So they were around for atleast a few years, and that leads right into the dianabol era.
